Navigation Links
New Treatment Rivals Chemotherapy For Lymphoma, Study Finds

icular non-Hodgkin's lymphoma after other treatments have failed. The newly published research involves Bexxar as a first-line treatment for this disease.

Non-Hodgkin's lymphoma, the nation's sixth leading cause of cancer death, is a cancer of the lymph system, which is part of the immune system. Lymphoma spreads easily through the lymph system and the bloodstream and consequently tends to be widespread when it is diagnosed. Traditional treatment often involves intensive chemotherapy, or a combination of chemotherapy and the monoclonal antibody rituximab. These treatments are usually given every three weeks over a span of up to six months and can cause many unpleasant side effects, including nausea, hair loss and infections.

Follicular lymphoma is the second most common type of non-Hodgkin's lymphoma and is not considered to be curable using these traditional treatments; even after patients initially have a response to treatment, the disease almost always comes back and becomes more difficult to treat.

Bexxar, whose chemical name is tositumomab and iodine I 131 tositumomab, combines an antibody that seeks out cancer cells, and a radioactive form of the element iodine. When injected, it travels like a guided missile through the bloodstream to bind to a protein found on the surface of the cancerous cells. The radiation zaps these malignant cells with minimal exposure to normal tissues.

With the Bexxar therapeutic regimen, a patient receives an injected test dose of radioactive Bexxar to determine how that patient's body processes the tagged antibody. Nuclear medicine scans are used to assess how quickly Bexxar reaches the tumor and how quickly the radiation disappears from the patient's body. One to two weeks after that initial dose, the patient then receives a custom-tailored therapeutic dose, and therapy is considered complete. The most common side effect is a temporary lowering of blood counts several weeks after the treatment. There
'"/>

Source:University Of Michigan Health System


Page: 1 2 3

Related biology news :

1. Discovery Could Lead To Novel Approaches In HIV Treatment
2. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
3. Effective Cancer Treatments Follow The Clock
4. Protein Discovery Could Unlock The Secret To Better TB Treatment
5. Natural Killers Could Lead to New Hepatitis Treatments
6. FDA Approves New Treatment for Chronic Hepatitis B
7. Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids
8. Drug Offers Alternative to Surgical Treatment After Miscarriage
9. Treatments have same target, different responses for lung cancer patients with genetic mutation
10. Minimally Invasive Cancer Treatments Highlighted
11. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Treatment Rivals Chemotherapy For Lymphoma Study Finds

(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Common food supplement fights degenerative brain disorders 2
... in Botswana, Harvard School of Public Health researchers have ... settings, who receive antiretroviral (ARV) therapy, can achieve comparable ... supported health care delivery system and infrastructure help ensure ... issue of the Journal of Acquired Immune Deficiency Syndromes ...
... in Botswana, Harvard School of Public Health researchers have ... settings, who receive antiretroviral (ARV) therapy, can achieve comparable ... supported health care delivery system and infrastructure help ensure ... issue of the Journal of Acquired Immune Deficiency Syndromes ...
... results from a study in Botswana, Harvard School of ... subtype C in resource-poor settings, who receive antiretroviral (ARV) ... developed world. A fully supported health care delivery system ... published in November 2005 issue of the Journal of ...
Cached Biology News:Largest computational biology simulation mimics life’s most essential nanomachine 2New Therapeutic Target Identified In Inherited Brain Tumor Disorder 2HIV-infected adults in Botswana respond positively to ARV therapy public treatment program 2
(Date:5/23/2013)... IL (PRWEB) May 23, 2013 Bed bugs ... against the pests is still ongoing, a report from kmov.com ... more for the bed bug treatment. Meanwhile, to be of ... apartment from the costly bed bug exterminator service. ... stated that AHA has so far spent $35,000 ...
(Date:5/23/2013)... Just released this month on Amazon and B&N is ... “Commit to Confidence: 30 Strategies to Help Women Step ... quotes from the fields of psychology and business, relevant and ... can do on their own or with a coach, this ... goals. , “My book is a five-chapter coaching ...
(Date:5/22/2013)... Cambridge Semantics was one of just ... Day” on Capitol Hill, hosted by The Data ... others to showcase how innovative data management applications can address ... (DATA Act). , Originally introduced in 2011 by Committee ... Mark Warner (D-VA ), the DATA Act is ...
(Date:5/22/2013)...  Superior Controls, Inc. has been named "Manufacturing/Technology ... Magazine.  For the past 22 years, the magazine ... with extraordinary business and civic excellence. ... said Rick Pierro , President ... award is a reflection of Superior Controls, continuing ...
Breaking Biology Technology:Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Global Nucleic Acid Testing Industry , ... http://www.reportlinker.com/p0209257/Global-Nucleic-Acid-Testing-Industry.html , , , ... for Nucleic Acid Testing in US$ Million. Annual estimates and forecasts are provided for the ...
... , , ... , , ... /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that ... of the Company,s lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) ...
... address biotechnology, science, policy and ethical issues , ... WASHINGTON , June 22 ... Drug Administration outlined a "path " to accelerate and help ensure ... genetic make-up.  Significant progress in this rapidly developing field will hinge on ...
Cached Biology Technology:Reportlinker Adds Global Nucleic Acid Testing Industry 2Reportlinker Adds Global Nucleic Acid Testing Industry 3Reportlinker Adds Global Nucleic Acid Testing Industry 4Reportlinker Adds Global Nucleic Acid Testing Industry 5Reportlinker Adds Global Nucleic Acid Testing Industry 6Reportlinker Adds Global Nucleic Acid Testing Industry 7Reportlinker Adds Global Nucleic Acid Testing Industry 8Reportlinker Adds Global Nucleic Acid Testing Industry 9Reportlinker Adds Global Nucleic Acid Testing Industry 10Resverlogix Scientific Data Presented at EAS Congress 2Resverlogix Scientific Data Presented at EAS Congress 3Resverlogix Scientific Data Presented at EAS Congress 4Pebbles Along the 'Path' to Personalized Medicine 2Pebbles Along the 'Path' to Personalized Medicine 3Pebbles Along the 'Path' to Personalized Medicine 4
Designed for flow cytometric applications intended to identify...
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins...
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
MOUSE ANTI RABBIT T LYMPHOCTYES Immunogen: Rabbit Thymocytes...
Biology Products: